DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bornaprolol
Bornaprolol
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Tetrapeptide Renin Inhibitors Having a Novel C-Terminal Amino Acid
Ovid MEDLINE(R)
Pharmaceutical Appendix to the Tariff Schedule 2
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Self-Measured Compared to Office
Multimedia Appendix 1. Search Strategy Developed for Medline Via Ovid to Identify Existing Systematics Review. Concept 1: BP
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Stembook 2018.Pdf
I (Acts Whose Publication Is Obligatory) COMMISSION
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
University of Groningen PET Imaging of Beta-Adrenoceptors in Human
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
The Pharmacological Treatment of Arterial Hypertension in Frail, Older Patients a Systematic Review
Pharmaceutical Appendix to the Tariff Schedule 2
Customs Tariff - Schedule Xxi - 1
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Pharmaceutical Appendix to the Tariff Schedule 2
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
(12) United States Patent (10) Patent No.: US 8,802,850 B2 Rao Et Al
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Identification and Characterization of Antidiabetic And